|1.||Corot, Claire: 10 articles (02/2011 - 06/2002)|
|2.||Robert, Philippe: 8 articles (06/2014 - 06/2002)|
|3.||Lu, Zheng-Rong: 5 articles (01/2015 - 03/2010)|
|4.||Wu, Xueming: 4 articles (01/2013 - 03/2010)|
|5.||Lindner, Daniel: 3 articles (01/2013 - 04/2012)|
|6.||Tan, Mingqian: 3 articles (08/2012 - 03/2010)|
|7.||Rémy, Chantal: 3 articles (11/2010 - 06/2008)|
|8.||Barbier, Emmanuel L: 3 articles (11/2010 - 06/2008)|
|9.||Lancelot, Eric: 3 articles (10/2010 - 03/2009)|
|10.||Kirchin, M A: 2 articles (09/2015 - 08/2004)|
12/01/1988 - "20 patients with a primary musculo skeletal tumor were investigated by MRI to assess the efficacy of Gd DOTA. "
05/01/2013 - "In the magnetic resonance imaging studies using control agent [Gd(DOTA)](-), the tumors with and without βG expression depicted no significant difference in enhancement on the T1-weighted images. "
05/01/1999 - "The objective of our study was to assess the feasibility of dynamic susceptibility contrast MR technique after bolus injection of SPIO and Gd-DOTA in a tumor model implanted in rats. "
01/01/2015 - "Tumor images of K (trans) (the volume transfer constant of Gd-DOTA) and v e (the fractional distribution volume of Gd-DOTA) were produced by pharmacokinetic analysis of the DCE-MRI data, and tumor images of ADC (the apparent diffusion coefficient) were produced from DW-MRI data. "
06/01/2014 - "Using P1227, specific enhancement of the angiogenic tumor rim, but not of normal muscle, was observed, whereas Gd-DOTA enhanced tumor and normal muscle. "
|2.||Renal Artery Obstruction (Renal Artery Stenosis)
03/01/2004 - "To investigate the diagnostic accuracy of non-enhanced Colour-Doppler US and enhanced power-Doppler US in the diagnosis of renal artery stenosis compared with breath-hold Gd-DOTA-enhanced MR-angiography. "
01/01/1996 - "Dynamic MR imaging can identify ACEI-induced Gd-DOTA tubular transit asymmetry, indicative of functionally significant renal artery stenoses, in rats."
06/01/2012 - "Low-dose gadobutrol (~0.05 mmoL/kg) contrast-enhanced MRA results in improved accuracy of renal artery stenosis assessments relative to equivalently dosed Gd-DOTA at 3 T."
01/01/1996 - "Thirteen rats, with surgically induced left renal artery stenosis, developed hypertension and were studied before and after intravenous injection of ACEI with sequential Gd-DOTA-enhanced MR imaging. "
06/01/2012 - "The aim of this study was to compare low-dose imaging with gadobutrol and gadoterate meglumine (Gd-DOTA) for evaluation of renal artery stenosis with 3-T magnetic resonance angiography (MRA) in a swine model. "
|3.||Renal Insufficiency (Renal Failure)
04/01/2001 - "Venography with Gd-DOTA is an effective and safe technique in planning AVFs for renal insufficiency patients."
04/01/2001 - "Over a 16-month period, 50 venographies were performed on end-stage renal insufficiency patients, using Gd-DOTA as a contrast agent on a high-resolution digital subtraction angiography system. "
10/01/2002 - "Over a 20-month period, 23 patients (15 women, eight men) with an age range of 42-87 years (mean, 63 years) having end-stage renal insufficiency and with recent hemodialysis fistula surgical placement underwent gadoterate-enhanced digital subtraction angiography with a digital 1024 x 1024 matrix. "
04/01/2001 - "The purpose of this study was to evaluate the feasibility, safety, and potential role of gadoterate meglumine (Gd-DOTA) as a contrast agent for upper extremity venography before the creation of an arteriovenous fistula (AVF) for nondialyzed renal insufficiency patients. "
|4.||Pathologic Constriction (Stenosis)
06/01/2002 - "Quantitative analysis was significantly improved by injection of a double versus a single dose of each CA (Gd-DOTA or P760), primarily in high degree stenosis. "
11/01/2012 - "[Arterial stenoses - diagnostic comparison of Gd-DOTA enhanced MRA and TOF-MRA]."
05/01/2012 - "We conclude that Gd-DOTA-enhanced MRA is a safe and accurate procedure for detecting arterial stenosis at both 1.5 T and 3 T."
06/01/2012 - "On time-resolved scans, peak signal-to-noise ratio was greatest with the gadobutrol protocol (P < 0.05), and the gadobutrol TWIST scan was preferred to the TWIST Gd-DOTA scan in terms of image quality and stenosis visualization in every case for every reader. "
06/01/2002 - "We qualitatively and quantitatively studied both 50 and 95% (300 microm diameter) stenosis of a 6 mm arterial phantom with two contrast agents (CA), Gd-DOTA (r(1)=2.9 mM(-1) s(-1)) versus P760 (r(1)=25 mM(-1) s(-1)) at several CA concentrations, including arterial peak concentration after injection of either a single or double dose of CA, using either a high temporal (booster) or high spatial (HR) resolution 3D MRA sequences. "
|5.||Sturge-Weber Syndrome (Sturge-Kalischer-Weber Syndrome)
07/01/1990 - "Gd-DOTA-enhanced MR imaging in two cases of Sturge-Weber syndrome."
07/01/1993 - "However, Gd-DOTA enhanced MR imaging improved the visualization of the angioma, localizing and demonstrating the extent of the malformation in Sturge Weber syndrome. "
07/01/1993 - "We report four patients with Sturge Weber syndrome in which the pial angioma was visualized better with Gd-DOTA enhanced MR imaging. "
|3.||Gadolinium DTPA (Magnevist)
|4.||Immunoglobulin G (IgG)
|9.||gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetate
|1.||Renal Dialysis (Hemodialysis)
|2.||Homologous Transplantation (Allograft)
|3.||Heterologous Transplantation (Xenotransplantation)